Dr Paul Korner promoted at Ferring
This article was originally published in Scrip
Executive Summary
Ferring Pharmaceuticals has promoted Dr Paul Korner to senior vice-president of the Ferring International PharmaScience Center US, its drug development subsidiary, where he will be responsible for the clinical management of US drug development. Dr Korner was previously vice-president of medical affairs for Ferring's infertility, orthopaedics, urology and gastroenterology therapeutic areas, as well as product safety.